News

TitleDate
Helius to Highlight Innovative PoNS TherapyTM at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS DayMay 24, 2023
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685Apr 17, 2023
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience ProgramJan 10, 2023
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple SclerosisJan 5, 2023
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to WalkJan 3, 2023
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience ProgramNov 10, 2022
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience ProgramNov 8, 2022
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their GaitNov 3, 2022
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their GaitOct 13, 2022
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™Jul 12, 2022
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual MeetingJun 6, 2022
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®Jun 1, 2022
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual ConferenceMay 31, 2022
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®May 12, 2022
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®Apr 27, 2022
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking AbilityApr 26, 2022
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®Dec 14, 2021
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial SiteNov 8, 2021
Helius Medical, Inc. Receives U.S. Marketing Authorization for the PoNS™ DeviceMar 29, 2021
Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory BoardOct 8, 2020
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple SclerosisMay 12, 2020